Parkman Healthcare Partners’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-903,140
| Closed | -$1.49M | – | 97 |
|
|
2024
Q3 | $1.49M | Sell |
903,140
-241,506
| -21% | -$398K | 0.19% | 82 |
|
|
2024
Q2 | $2.54M | Buy |
1,144,646
+1,749
| +0.2% | +$3.88K | 0.34% | 69 |
|
|
2024
Q1 | $3.06M | Sell |
1,142,897
-282,307
| -20% | -$757K | 0.38% | 71 |
|
|
2023
Q4 | $4.26M | Sell |
1,425,204
-571,867
| -29% | -$1.71M | 0.6% | 54 |
|
|
2023
Q3 | $1.96M | Sell |
1,997,071
-135,238
| -6% | -$133K | 0.36% | 75 |
|
|
2023
Q2 | $2.96M | Buy |
2,132,309
+253,452
| +13% | +$352K | 0.51% | 59 |
|
|
2023
Q1 | $2.99M | Buy |
1,878,857
+1,056,073
| +128% | +$1.68M | 0.65% | 48 |
|
|
2022
Q4 | $5.13M | Buy |
822,784
+526,403
| +178% | +$3.28M | 1.36% | 25 |
|
|
2022
Q3 | $1.99M | Buy |
+296,381
| New | +$1.99M | 0.56% | 56 |
|